Study of a test battery for thinking and language skills
Part of Brain & nervous system, Mental health clinical trials.
This study evaluates a test battery (ExéSem) that helps doctors understand how executive functions (like planning and problem-solving) contribute to language and meaning disorders. Participants will complete cognitive tasks, and the results may help improve diagnosis and care for people with certain memory or language conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 90 years old.
- Your native language must be French.
- You either have no cognitive problems, or you have a diagnosed condition like Alzheimer's, vascular cognitive impairment, or a specific language disorder (semantic variant of primary progressive aphasia).
- If you have cognitive issues, your Mini-Mental State Exam (MMSE) score must be 20 or higher out of 30.
- You cannot have severe unstable medical conditions, substance use affecting thinking, or significant hearing/vision loss.
- You must be able to consent and not be under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Alzheimer's disease and similar conditions affect social and emotional thinking. Researchers will use brain scans and questionnaires to understand these changes better.
This study looks at how well people can pay attention and remember information during testing. It may help researchers understand “source monitoring” (how you tell where a thought or memory came from) in people with certain neuropsychiatric conditions.
This study looks at how thinking and language work in people with certain brain conditions, using a simple word-finding task and brain scans. It may help researchers better understand what brain changes are linked to different symptoms.
This study looks at memory and thinking changes using questionnaires, memory testing, and brain scans. It may help researchers better understand neurodegeneration and dementia and how these problems show up over time.
This trial checks a new kind of paper-and-pen (or computer-based) test to better measure thinking and social/behavior skills in people with certain brain diseases. It may help researchers improve how these skills are tracked and understood over time.
This trial studies whether automated analysis of your voice and speech can help detect early signs of Alzheimer’s disease and mood (affective) problems. It may help identify changes sooner, using voice and questionnaire information from people who are cognitively healthy to very mildly affected.
Hear when a new Alzheimer’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.